XNYS 15 Oct, 2026 3:16 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 21 Sep 2026 | 2,027 | 297,084 (1%) | 0% | 2.0 | 4,105 | - |
| Mr. Howard S. Jonas | Director, Exec Chairman, CEO & President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 2.73 per share. | 29 Jul 2026 | 54,945 | 512,030 (3%) | 0% | 2.7 | 150,000 | Class B Common Stock, $.01 par value per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.63 per share. | 21 Jun 2026 | 2,386 | 299,111 (1%) | 0% | 2.6 | 6,287 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, Exec Chairman, CEO & President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.33 per share. | 13 Jun 2026 | 8,786 | 314,228 (2%) | 0% | 2.3 | 20,471 | Class B Common Stock, $.01 par value per share |
| Mr. Howard S. Jonas | Director, Exec Chairman, CEO & President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.75 per share. | 13 Jun 2026 | 142,857 | 457,085 (3%) | 0% | 1.8 | 250,000 | Class B Common Stock, $.01 par value per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.27 per share. | 21 Mar 2026 | 2,318 | 301,497 (2%) | 0% | 1.3 | 2,955 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.27 per share. | 21 Mar 2026 | 2,318 | 301,497 (2%) | 0% | 1.3 | 2,955 | - |
| Mr. Howard S. Jonas | Director, Exec Chairman, CEO & President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.50 per share. | 13 Mar 2026 | 9,826 | 323,014 (2%) | 0% | 1.5 | 14,764 | Class B Common Stock, $.01 par value per share |
| Dr. Michael J. Weiss, M.D. | Director | Grant, award, or other acquisition of securities at price $ 1.27 per share. | 28 Jan 2026 | 39,370 | 141,861 (0%) | 0% | 1.3 | 50,000 | Class B Common Stock, par value $.01 per share |
| Dr. Mark N. Stein, M.D. | Director | Grant, award, or other acquisition of securities at price $ 1.27 per share. | 28 Jan 2026 | 39,370 | 50,845 (0%) | 0% | 1.3 | 50,000 | Class B Common Stock, par value $.01 per share |
| Mr. Alan Grayson | Director | Grant, award, or other acquisition of securities at price $ 1.27 per share. | 28 Jan 2026 | 6,562 | 6,562 (0%) | 0% | 1.3 | 8,334 | Class B Common Stock, par value $.01 per share |
| Mr. Markus W. Sieger | Director | Grant, award, or other acquisition of securities at price $ 1.27 per share. | 28 Jan 2026 | 29,528 | 219,710 (1%) | 0% | 1.3 | 37,501 | Class B Common Stock, par value $.01 per share |
| Dr. Michael J. Weiss, M.D. | Director | Grant, award, or other acquisition of securities at price $ 1.27 per share. | 28 Jan 2026 | 39,370 | 141,861 (0%) | 0% | 1.3 | 50,000 | - |
| Mr. Howard S. Jonas | Director, Exec Chairman, CEO & President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.25 per share. | 13 Jan 2026 | 75,000 | 332,840 (2%) | 0% | 1.2 | 93,638 | Class B Common Stock, $.01 par value per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.25 per share. | 13 Jan 2026 | 4,865 | 253,815 (1%) | 0% | 1.2 | 6,074 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.25 per share. | 13 Jan 2026 | 50,000 | 303,815 (2%) | 0% | 1.2 | 62,425 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.25 per share. | 13 Jan 2026 | 4,865 | 253,815 (1%) | 0% | 1.2 | 6,074 | - |
| Mr. David Polinsky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.25 per share. | 13 Jan 2026 | 50,000 | 303,815 (2%) | 0% | 1.2 | 62,425 | - |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.29 per share. | 21 Dec 2025 | 1,961 | 258,680 (1%) | 0% | 1.3 | 2,520 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.29 per share. | 21 Dec 2025 | 1,961 | 258,680 (1%) | 0% | 1.3 | 2,520 | - |
| Mr. Howard S. Jonas | Director, Exec Chairman, CEO & President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.50 per share. | 13 Dec 2025 | 9,867 | 257,840 (1%) | 0% | 1.5 | 14,776 | Class B Common Stock, $.01 par value per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.35 per share. | 25 Oct 2025 | 4,180 | 260,641 (1%) | 0% | 1.4 | 5,643 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.35 per share. | 25 Oct 2025 | 4,180 | 260,641 (1%) | 0% | 1.4 | 5,643 | - |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.48 per share. | 23 Sep 2025 | 1,284 | 264,821 (1%) | 0% | 1.5 | 1,900 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.48 per share. | 23 Sep 2025 | 1,284 | 264,821 (1%) | 0% | 1.5 | 1,900 | - |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.49 per share. | 21 Sep 2025 | 1,970 | 266,105 (1%) | 0% | 1.5 | 2,935 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.49 per share. | 21 Sep 2025 | 1,970 | 266,105 (1%) | 0% | 1.5 | 2,935 | - |
| Mr. Howard S. Jonas | Director, Exec Chairman, CEO & President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.34 per share. | 13 Sep 2025 | 9,905 | 267,707 (1%) | 0% | 1.3 | 13,322 | Class B Common Stock, $.01 par value per share |
| Mr. Joshua M. Fine | Chief Operating Officer | 03 Sep 2025 | 24,558 | 24,558 | - | - | Stock Options (right to buy) | ||
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.59 per share. | 21 Jun 2025 | 2,347 | 268,075 (1%) | 0% | 1.6 | 3,743 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.59 per share. | 21 Jun 2025 | 2,347 | 268,075 (1%) | 0% | 1.6 | 3,743 | - |
| Mr. Howard S. Jonas | Director, Exec Chairman, CEO & President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 2.11 per share. | 13 Jun 2025 | 118,596 | 277,612 (1%) | 0% | 2.1 | 250,000 | Class B Common Stock, $.01 par value per share |
| Mr. Howard S. Jonas | Director, Exec Chairman, CEO & President, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 05 Jun 2025 | 12,299,207 | 12,299,207 (81%) | 81% | 1.3 | 15,742,985 | Class B Common Stock, $.01 par value per share |
| Mr. Howard S. Jonas | Director, Exec Chairman, CEO & President, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 05 Jun 2025 | 324,219 | 324,219 (2%) | 2% | 1.3 | 415,000 | Class B Common Stock, $.01 par value per share |
| Mr. Howard S. Jonas | Director, Exec Chairman, CEO & President, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 05 Jun 2025 | 457,031 | 457,031 (3%) | 3% | 1.3 | 585,000 | Class B Common Stock, $.01 par value per share |
| Mr. David Polinsky | Chief Financial Officer | 29 May 2025 | 76,882 | 0 | - | - | Class B Common Stock | ||
| Mr. David Polinsky | Chief Financial Officer | 29 May 2025 | 76,882 | 270,422 (1%) | 0% | 1.3 | 98,409 | Class B Common Stock, par value $.01 per share | |
| Mr. David Polinsky | Chief Financial Officer | 29 May 2025 | 76,882 | 270,422 (1%) | 0% | 1.3 | 98,409 | - | |
| Mr. Markus W. Sieger | Director | 27 May 2025 | 35,000 | 190,182 (1%) | 0% | 1.3 | 44,800 | Class B Common Stock, par value $.01 per share | |
| Mr. Markus W. Sieger | Director | 27 May 2025 | 35,000 | 0 | - | - | Subscription Rights (right to buy) | ||
| Mr. William Conkling | Chief Executive Officer | 25 Mar 2025 | 5,485 | 5,485 | - | - | Employee Stock Option (right to buy) | ||
| Mr. William Conkling | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 27,454 | 564,455 (3%) | 0% | - | Class B Common Stock, par value $.01 per share | |
| Mr. William Conkling | Chief Executive Officer | 25 Mar 2025 | 2,362 | 2,362 | - | - | Employee Stock Option (right to buy) | ||
| Mr. William Conkling | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 27,454 | 564,455 (3%) | 0% | - | - | |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.93 per share. | 21 Mar 2025 | 2,378 | 193,540 (1%) | 0% | 1.9 | 4,590 | Class B Common Stock, par value $.01 per share |
| Mr. William Conkling | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.93 per share. | 21 Mar 2025 | 14,814 | 537,001 (3%) | 0% | 1.9 | 28,591 | Class B Common Stock, par value $.01 per share |
| Mr. William Conkling | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.93 per share. | 21 Mar 2025 | 14,814 | 537,001 (3%) | 0% | 1.9 | 28,591 | - |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.93 per share. | 21 Mar 2025 | 2,378 | 193,540 (1%) | 0% | 1.9 | 4,590 | - |
| Mr. David Polinsky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.95 per share. | 13 Jan 2025 | 50,000 | 195,918 (1%) | 0% | 2.0 | 97,700 | Class B Common Stock, par value $.01 per share |
| Dr. John M. Goldberg, M.D. | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 1.95 per share. | 13 Jan 2025 | 50,000 | 50,000 (0%) | 0% | 2.0 | 97,700 | Class B Common Stock, par value $.01 per share |
| Mr. William Conkling | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.95 per share. | 13 Jan 2025 | 60,000 | 551,815 (3%) | 0% | 2.0 | 117,240 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.95 per share. | 13 Jan 2025 | 50,000 | 195,918 (1%) | 0% | 2.0 | 97,700 | - |
| Mr. William Conkling | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.95 per share. | 13 Jan 2025 | 60,000 | 551,815 (3%) | 0% | 2.0 | 117,240 | - |
| Mr. Stephen M. Greenberg | Director | Grant, award, or other acquisition of securities at price $ 1.82 per share. | 06 Jan 2025 | 27,541 | 102,491 (0%) | 0% | 1.8 | 50,125 | Class B Common Stock, par value $.01 per share |
| Dr. Michael J. Weiss, M.D. | Director | Grant, award, or other acquisition of securities at price $ 1.82 per share. | 06 Jan 2025 | 27,541 | 102,491 (0%) | 0% | 1.8 | 50,125 | Class B Common Stock, par value $.01 per share |
| Dr. Mark N. Stein, M.D. | Director | Grant, award, or other acquisition of securities at price $ 1.82 per share. | 06 Jan 2025 | 11,475 | 11,475 (0%) | 0% | 1.8 | 20,885 | Class B Common Stock, par value $.01 per share |
| Dr. Michael J. Weiss, M.D. | Director | Grant, award, or other acquisition of securities at price $ 1.82 per share. | 06 Jan 2025 | 27,541 | 102,491 (0%) | 0% | 1.8 | 50,125 | - |
| Mr. Stephen Greenberg | Director | Grant, award, or other acquisition of securities at price $ 1.82 per share. | 06 Jan 2025 | 27,541 | 102,491 (0%) | 0% | 1.8 | 50,125 | - |
| Polinsky David | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.84 per share. | 21 Dec 2024 | 2,002 | 145,918 (0%) | 0% | 1.8 | 3,674 | Class B Common Stock, par value $.01 per share |
| Conkling William | Chief Executive Officer | 21 Dec 2024 | 12,807 | 491,815 (3%) | 0% | 1.8 | 23,501 | Class B Common Stock, par value $.01 per share | |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.84 per share. | 25 Oct 2024 | 3,331 | 147,920 (0%) | 0% | 1.8 | 6,129 | Class B Common Stock, par value $.01 per share |
| Mr. William Conkling | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.84 per share. | 25 Oct 2024 | 3,431 | 504,622 (3%) | 0% | 1.8 | 6,313 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.72 per share. | 21 Sep 2024 | 1,431 | 151,251 (1%) | 0% | 1.7 | 2,468 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.72 per share. | 21 Sep 2024 | 2,384 | 152,682 (1%) | 0% | 1.7 | 4,112 | Class B Common Stock, par value $.01 per share |
| Mr. William Conkling | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.73 per share. | 21 Sep 2024 | 12,696 | 508,053 (3%) | 0% | 1.7 | 21,901 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 24 Jul 2024 | 563,538 | 0 (0%) | 3% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 24 Jul 2024 | 563,538 | 563,538 (3%) | 3% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 26 Jun 2024 | 563,538 | 563,538 (3%) | 3% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 26 Jun 2024 | 563,538 | 0 (0%) | 3% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. | 21 Jun 2024 | 2,296 | 155,066 (1%) | 0% | 1.5 | 3,341 | Class B Common Stock, par value $.01 per share |
| Mr. William Conkling | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. | 21 Jun 2024 | 13,295 | 520,749 (3%) | 0% | 1.5 | 19,344 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 159,016 | 722,554 (4%) | 1% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 13 Jun 2024 | 187,427 | 563,538 (3%) | 1% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 13 Jun 2024 | 187,427 | 159,016 (1%) | 1% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 13 Jun 2024 | 376,111 | 376,111 (2%) | 2% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 13 Jun 2024 | 376,111 | 346,443 (2%) | 2% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 04 Apr 2024 | 348,259 | 563,538 (3%) | 2% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 04 Apr 2024 | 348,259 | 0 (0%) | 2% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.71 per share. | 21 Mar 2024 | 2,300 | 157,362 (1%) | 0% | 1.7 | 3,922 | Class B Common Stock, par value $.01 per share |
| Mr. William Conkling | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.70 per share. | 21 Mar 2024 | 15,473 | 534,044 (3%) | 0% | 1.7 | 26,381 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 30 Jan 2024 | 348,259 | 215,279 (1%) | 2% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 30 Jan 2024 | 348,259 | 348,259 (2%) | 2% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. John M. Goldberg, M.D. | CHIEF MEDICAL OFFICER | 16 Jan 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | ||
| Dr. Michael J. Weiss, M.D. | Director | Grant, award, or other acquisition of securities at price $ 1.81 per share. | 05 Jan 2024 | 27,655 | 74,950 (0%) | 0% | 1.8 | 50,056 | Class B Common Stock, par value $.01 per share |
| Mr. Stephen M. Greenberg | Director | Grant, award, or other acquisition of securities at price $ 1.81 per share. | 05 Jan 2024 | 27,655 | 74,950 (0%) | 0% | 1.8 | 50,056 | Class B Common Stock, par value $.01 per share |
| Dr. Mark A. Mccamish, M.D.,PhD | Director | Grant, award, or other acquisition of securities at price $ 1.81 per share. | 05 Jan 2024 | 27,655 | 60,241 (0%) | 0% | 1.8 | 50,056 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.82 per share. | 21 Dec 2023 | 8,577 | 159,662 (1%) | 0% | 1.8 | 15,610 | Class B Common Stock, par value $.01 per share |
| Mr. William Conkling | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.82 per share. | 21 Dec 2023 | 13,602 | 549,517 (3%) | 0% | 1.8 | 24,756 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.52 per share. | 25 Oct 2023 | 40,000 | 168,239 (1%) | 0% | 1.5 | 60,600 | Class B Common Stock, par value $.01 per share |
| Mr. William Conkling | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.52 per share. | 25 Oct 2023 | 40,000 | 563,119 (3%) | 0% | 1.5 | 60,600 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.04 per share. | 23 Sep 2023 | 2,541 | 128,239 (0%) | 0% | 2.0 | 5,171 | Class B Common Stock, par value $.01 per share |
| Mr. William Conkling | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.20 per share. | 21 Sep 2023 | 13,669 | 523,119 (3%) | 0% | 2.2 | 30,140 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 2.24 per share. | 28 Aug 2023 | 111,408 | 563,538 (3%) | 0% | 2.2 | 250,000 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 31 Jul 2023 | 787,163 | 787,163 | - | 0 | Class A Common Stock, par value $.01 per share | |
| Mr. William Conkling | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.15 per share. | 21 Jun 2023 | 15,170 | 536,788 (3%) | 0% | 2.2 | 32,616 | Class B Common Stock, par value $.01 per share |
| Mr. William Conkling | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.67 per share. | 21 Mar 2023 | 15,625 | 551,958 (3%) | 0% | 1.7 | 26,094 | Class B Common Stock, par value $.01 per share |
| Dr. Mark A. Mccamish, M.D.,PhD | Director | Grant, award, or other acquisition of securities at price $ 1.84 per share. | 05 Jan 2023 | 27,174 | 32,586 (0%) | 0% | 1.8 | 50,000 | Class B Common Stock, par value $.01 per share |
| Mr. Stephen Greenberg | Director | Grant, award, or other acquisition of securities at price $ 1.84 per share. | 05 Jan 2023 | 27,174 | 47,295 (0%) | 0% | 1.8 | 50,000 | Class B Common Stock, par value $.01 per share |
| Dr. Boris C. Pasche, M.D.,PhD | Director | Grant, award, or other acquisition of securities at price $ 1.84 per share. | 05 Jan 2023 | 27,174 | 47,295 (0%) | 0% | 1.8 | 50,000 | Class B Common Stock, par value $.01 per share |
| Dr. Michael J. Weiss, M.D. | Director | Grant, award, or other acquisition of securities at price $ 1.84 per share. | 05 Jan 2023 | 27,174 | 47,295 (0%) | 0% | 1.8 | 50,000 | Class B Common Stock, par value $.01 per share |
| Mr. Patrick Fabbio | CFO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.76 per share. | 21 Dec 2022 | 27,928 | 335,175 (2%) | 0% | 1.8 | 49,153 | Class B Common Stock, par value $.01 per share |
| Mr. William Conkling | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.76 per share. | 21 Dec 2022 | 56,149 | 567,583 (3%) | 0% | 1.8 | 98,822 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 1.84 per share. | 05 Aug 2022 | 64,674 | 3,225,806 (21%) | 0% | 1.8 | 118,948 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 1.93 per share. | 05 Aug 2022 | 33,100 | 3,305,267 (21%) | 0% | 1.9 | 64,019 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 1.94 per share. | 05 Aug 2022 | 14,787 | 3,290,480 (21%) | 0% | 1.9 | 28,678 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 1.86 per share. | 06 Jul 2022 | 3,225,806 | 3,338,367 (22%) | 21% | 1.9 | 5,999,999 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 1.88 per share. | 14 Jun 2022 | 132,980 | 132,980 (0%) | 0% | 1.9 | 250,002 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 1.88 per share. | 14 Jun 2022 | 319,150 | 452,130 (3%) | 2% | 1.9 | 600,002 | Class B Common Stock, par value $.01 per share |
| Mr. Patrick Fabbio | CFO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 363,103 | 363,103 (2%) | 2% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. William Conkling | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 623,732 | 623,732 (4%) | 4% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Ameet Mallik | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Feb 2022 | 908,497 | 0 (0%) | 6% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Stephen Greenberg | Director | Grant, award, or other acquisition of securities at price $ 5.39 per share. | 19 Jan 2022 | 7,512 | 20,121 (0%) | 0% | 5.4 | 40,490 | Class B Common Stock, par value $.01 per share |
| Dr. Michael J. Weiss, M.D. | Director | Grant, award, or other acquisition of securities at price $ 5.39 per share. | 19 Jan 2022 | 7,512 | 20,121 (0%) | 0% | 5.4 | 40,490 | Class B Common Stock, par value $.01 per share |
| Dr. Mark A. Mccamish, M.D.,PhD | Director | Grant, award, or other acquisition of securities at price $ 5.39 per share. | 05 Jan 2022 | 5,412 | 5,412 (0%) | 0% | 5.4 | 29,171 | Class B Common Stock, par value $.01 per share |
| Dr. Boris C. Pasche, M.D.,PhD | Director | Grant, award, or other acquisition of securities at price $ 5.39 per share. | 05 Jan 2022 | 7,512 | 20,121 (0%) | 0% | 5.4 | 40,490 | Class B Common Stock, par value $.01 per share |
| Ms. Shannon Thyme Klinger | Director | Grant, award, or other acquisition of securities at price $ 5.39 per share. | 05 Jan 2022 | 5,412 | 5,412 (0%) | 0% | 5.4 | 29,171 | Class B Common Stock, par value $.01 per share |
| Ms. Mary Margaret Huizinga | Chief Devel. & Medical Officer | 18 Oct 2021 | 122,341 | 122,341 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Ashok D. Marin | Chief Legal Officer | 24 Sep 2021 | 34,066 | 34,066 | - | - | Employee Stock Option (right to buy) | ||
| Mr. David Polinsky | Former Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.77 per share. | 23 Sep 2021 | 571 | 17,429 (0%) | 0% | 35.8 | 20,425 | Class B Common Stock, par value $.01 per share |
| Mr. Patrick Fabbio | Chief Financial Officer | 17 Sep 2021 | 105,602 | 105,602 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Howard S. Jonas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 44.92 per share. | 24 Aug 2021 | 112,561 | 112,561 (0%) | 0% | 44.9 | 5,056,240 | Class B Common Stock, par value $.01 per share |
| Mr. Ameet Mallik | CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 44.70 per share. | 27 May 2021 | 908,497 | 908,497 (6%) | 6% | 44.7 | 40,609,816 | Class B Common Stock, par value $.01 per share |
| Mr. William Conkling | Chief Commercial Officer | 15 Apr 2021 | 118,409 | 118,409 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Ash Menachem | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.72 per share. | 05 Jan 2021 | 5,405 | 126,440 (0%) | 0% | 22.7 | 122,802 | Class B Common Stock, par value $.01 per share |
| Mr. Stephen Greenberg | Director | Grant, award, or other acquisition of securities at price $ 22.72 per share. | 05 Jan 2021 | 4,203 | 12,609 (0%) | 0% | 22.7 | 95,492 | Class B Common Stock, par value $.01 per share |
| Dr. Boris C. Pasche, M.D.,PhD | Director | Grant, award, or other acquisition of securities at price $ 22.72 per share. | 05 Jan 2021 | 4,203 | 12,609 (0%) | 0% | 22.7 | 95,492 | Class B Common Stock, par value $.01 per share |
| Dr. Michael J. Weiss, M.D. | Director | Grant, award, or other acquisition of securities at price $ 22.72 per share. | 05 Jan 2021 | 4,203 | 12,609 (0%) | 0% | 22.7 | 95,492 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2020 | 5,000 | 18,000 (0%) | 0% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Apr 2020 | 32,711 | 0 (0%) | 0% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Apr 2020 | 787,163 | 0 | - | 0 | Class A Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Apr 2020 | 4,306,738 | 32,711 (0%) | 28% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Ash Menachem | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.16 per share. | 24 Jan 2020 | 5,238 | 131,845 (0%) | 0% | 22.2 | 116,048 | Class B Common Stock, par value $.01 per share |
| Mr. Stephen Greenberg | Director | Grant, award, or other acquisition of securities at price $ 16.68 per share. | 06 Jan 2020 | 4,203 | 8,406 (0%) | 0% | 16.7 | 70,127 | Class B Common Stock, par value $.01 per share |
| Dr. Boris C. Pasche, M.D.,PhD | Director | Grant, award, or other acquisition of securities at price $ 16.68 per share. | 06 Jan 2020 | 4,203 | 8,406 (0%) | 0% | 16.7 | 70,127 | Class B Common Stock, par value $.01 per share |
| Dr. Michael J. Weiss, M.D. | Director | Grant, award, or other acquisition of securities at price $ 16.68 per share. | 06 Jan 2020 | 4,203 | 8,406 (0%) | 0% | 16.7 | 70,127 | Class B Common Stock, par value $.01 per share |
| Mr. David Polinsky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2019 | 5,000 | 13,000 (0%) | 0% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 8.47 per share. | 07 Aug 2019 | 1,849,749 | 4,339,449 (28%) | 12% | 8.5 | 15,667,374 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 25 Jun 2019 | 1,265,804 | 0 (0%) | 9% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 25 Jun 2019 | 1,265,804 | 2,489,700 (16%) | 9% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Ash Menachem | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2019 | 70,718 | 137,083 (0%) | 0% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 6.89 per share. | 18 Jan 2019 | 1,254,200 | 1,265,804 (8%) | 10% | 6.9 | 8,641,438 | Class B Common Stock, par value $.01 per share |
| Mr. Stephen Greenberg | None | Grant, award, or other acquisition of securities at price $ 8.47 per share. | 05 Jan 2019 | 4,203 | 4,203 (0%) | 0% | 8.5 | 35,599 | Class B Common Stock, par value $.01 per share |
| Dr. Boris C. Pasche, M.D.,PhD | None | Grant, award, or other acquisition of securities at price $ 8.47 per share. | 05 Jan 2019 | 4,203 | 4,203 (0%) | 0% | 8.5 | 35,599 | Class B Common Stock, par value $.01 per share |
| Dr. Michael J. Weiss, M.D. | None | Grant, award, or other acquisition of securities at price $ 8.47 per share. | 05 Jan 2019 | 4,203 | 4,203 (0%) | 0% | 8.5 | 35,599 | Class B Common Stock, par value $.01 per share |
| Mr. Ash Menachem | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 18 Jul 2018 | 643 | 66,365 (0%) | 0% | 9.4 | 6,025 | Class B Common Stock, par value $.01 per share |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jul 2018 | 225,556 | 1,223,896 (10%) | 1% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jul 2018 | 225,556 | 0 (0%) | 1% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jul 2018 | 32,711 | 998,340 (8%) | 0% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jul 2018 | 32,711 | 11,604 (0%) | 0% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jul 2018 | 97,491 | 965,629 (8%) | 0% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jul 2018 | 97,491 | 44,315 (0%) | 0% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jul 2018 | 787,163 | 787,163 (0%) | 0% | 0 | Class A Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jul 2018 | 787,163 | 0 (0%) | 0% | 0 | Class A Common Stock, par value $.01 per share | |
| Ms. Joyce J. Mason | Other | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2018 | 3,000 | 17,638 (0%) | 0% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Ash Menachem | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2018 | 58,200 | 67,008 (0%) | 0% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. David Polinsky | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2018 | 8,000 | 8,000 (0%) | 0% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 26 Mar 2018 | 11,639,901 | 0 (0%) | 100% | 0 | Class B Common Stock, par value $.01 per share | |
| Mr. Howard S. Jonas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 26 Mar 2018 | 787,163 | 0 (0%) | 0% | 0 | Class A Common Stock, par value $.01 per share |